ClinicalTrials.gov
public full text
Public Domain
A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid Tumors
breast-cancerfollicular-lymphomahead-and-neck-cancermultiple-myelomaovarian-cancerpancreatic-cancersoft-tissue-sarcoma
This clinical trial is an interventional, active-treatment, open-label, multi-center, Phase 1/2 study. The study objectives are to assess the safety, tolerability and pharmacokinetics (PK) of CYT-0851 in patients with relapsed/refractory B-cell malignancies and advanced solid tumors and to identify a recommended Phase 2 dose as a monotherapy and in combination with chemotherapy for evaluation in these patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of BA1106 in Advanced Solid Tumors#918144
- Phase I Ascending Multiple-Dose Study of BMS-986115 in Subjects With Advanced Solid Tumors#845405
- Study of CM518D1 in Patients With Advanced Solid Tumors#1185822
- A Study of MHB046C Injection in Patients With Advanced Solid Tumors#867443
- BM201 in Combination With Radiotherapy in Patients With Advanced Solid Tumors#1185721
Record · ID 1439287
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive